SCHEMBL4957308

SCHEMBL4957308

CC(Nc1ccccn1)C(=O)N1CCC[C@H]1C(N)=O

nearest known ligand 0.45

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ ACE P12821 3/20 0.45
▸ MEN1 O00255 1/20 0.43
▸ HTT P42858 1/20 0.43
▸ KMT2A Q03164 1/20 0.43
▸ ERAP2 Q6P179 1/20 0.41
▸ ERAP1 Q9NZ08 1/20 0.41
▸ LNPEP Q9UIQ6 1/20 0.41
▸ VNN1 O95497 1/20 0.41
▸ HCRTR2 O43614 1/20 0.41
▸ PIK3CA P42336 3/20 0.41
▸ PIK3CD O00329 1/20 0.41
▸ PIK3CB P42338 1/20 0.41
▸ PIK3CG P48736 1/20 0.41
▸ DPP4 P27487 2/20 0.40
▸ PREP P48147 2/20 0.40
▸ FAP Q12884 2/20 0.40
▸ LMNA P02545 1/20 0.40
▸ RAB9A P51151 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4957323 1.00 ACE (0.45) ACEMEN1HTTKMT2AERAP2
SCHEMBL6273381 0.80 MEN1 (0.53) MEN1HTTKMT2APIK3CAPIK3CD
SCHEMBL8205698 0.79 MEN1 (0.48) ACEMEN1KMT2ALMNA
SCHEMBL4957316 0.77 MAPK10 (0.48) MEN1HTTKMT2AHCRTR2DPP4
SCHEMBL26616469 0.77 FKBP1A (0.45) ACEERAP2ERAP1LNPEPDPP4
SCHEMBL26616464 0.77 FKBP1A (0.45) ACEERAP2ERAP1LNPEPDPP4
Trifluoroacetic Acid SCHEMBL9551619 0.76 ACE (0.47) ACEHTTERAP2ERAP1LNPEP
SCHEMBL26616429 0.75 PREP (0.67) ACEDPP4PREPFAP
SCHEMBL26616424 0.75 PREP (0.67) ACEDPP4PREPFAP
SCHEMBL17345293 0.74 PREP (0.69) ACEDPP4PREPFAP

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0144230-B1 GROWTH PROMOTANTS FOR ANIMALS Pfizer Limited (GB) 1990-08-08 — — EP claimed
EP-0144230-A2 Growth promotants for animals Pfizer Limited (GB) 1985-06-12 — — EP claimed
US-7371721-B2 Use of GLP-2 and related compounds for the treatment, prevention, diagnosis, and prognosis of bone-related disorders and calcium homeostasis related syndromes SANOS BIOSCIENCE A/S (DK) 2008-05-13 — — US disclosed
US-20050282749-A1 Use of GLP-2 and related compounds for the treatment, prevention, diagnosis, and prognosis of bone-related disorders and calcium homeostasis related syndromes SANOS BIOSCIENCE A/S 2005-12-22 — — US disclosed
Send feedback